Drupal.behaviors.print = function(context) {window.print();window.close();}>
Roche, ChanTest Ink Deal to Evaluate Safety of Compounds
December 05, 2011
Roche, ChanTest Ink Deal to Evaluate Safety of Compounds
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
BioFocus to Offer ChanTest Cell Line Library, Services
February 6, 2013 / GenomeWeb Daily News
ChanTest, FDA Partner on Cardiac Safety Assays
June 10, 2011 / GenomeWeb Daily News
Molecular Devices Inks Deal with ChanTest for Ion Channel, GPCR Cell Lines
March 24, 2011 / GenomeWeb Daily News
Roche Receives FDA Nod for New PGx Indication for Tarceva in Metastatic NSCLC with Companion Dx
May 15, 2013 / Pharmacogenomics Reporter
FDA Approves Roche Test as CDx for Tarceva for Treating Certain NSCLC Patients
May 15, 2013 / GenomeWeb Daily News